Concentrix (CNXC) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
3 Apr, 2026Executive summary
Q1 2026 revenue grew 5.4% year-over-year to $2.5 billion, driven by strong AI-enabled solutions, particularly the iX suite, and robust demand in banking, financial services, insurance, travel, retail, and e-commerce, though technology, consumer electronics, and healthcare declined.
Revenue and profitability were in line with guidance, but operating income and net income declined sharply due to higher costs, restructuring, and increased SG&A expenses.
AI-related wins, especially with the iX suite, saw significant growth, with annual contract value for AI solutions more than doubling quarter-on-quarter and major contracts closed with Fortune 50 clients.
Continued investment in proprietary technology, efficiency initiatives, and long-term programs is expected to support future revenue and margin growth.
CEO emphasized measurable client value from AI and a focus on long-term growth.
Financial highlights
Q1 2026 revenue was $2.5 billion, up 5.4% year-over-year (1.9% constant currency); non-GAAP operating income was $295 million, and adjusted EBITDA was $348.2 million with a 13.9% margin.
Non-GAAP diluted EPS was $2.61, down from $2.79 year-over-year; GAAP diluted EPS was $0.33, down from $1.04.
Adjusted free cash flow was negative $144.6 million, reflecting seasonal factors, higher capital expenditures, and timing of cash receipts.
Net debt at quarter-end was $4.51 billion; liquidity was nearly $1.4 billion, including $1.1 billion undrawn on the revolving credit facility.
Returned $65 million to shareholders in Q1 via share repurchases and dividends.
Outlook and guidance
Q2 2026 revenue expected between $2.46 billion and $2.485 billion, with constant currency growth of 1% to 2%; Q2 non-GAAP operating income guidance is $290 million to $300 million, and non-GAAP EPS expected between $2.57 and $2.69.
Full-year 2026 revenue guidance is $10.035 billion to $10.18 billion, with constant currency growth of 1.5% to 3.0%; non-GAAP operating income guidance is $1.24 billion to $1.29 billion.
Full-year adjusted free cash flow guidance reaffirmed at $630 million to $650 million.
Net leverage targeted to fall below 2.6x adjusted EBITDA by fiscal year-end.
Future cash dividends anticipated quarterly, subject to board approval and financial conditions.
Latest events from Concentrix
- AI-driven IX suite accelerates margin growth and cash flow, supporting debt reduction and future value.CNXC
Canaccord Genuity's 46th Annual Growth Conference - Q2 revenue up 1.9% with record cash flow, but margins fell amid restructuring costs.CNXC
Q2 2026 - All voting items, including director elections and stock plan amendment, were approved.CNXC
AGM 2026 - Supplement clarifies voting rules for a key stock incentive plan amendment proposal.CNXC
Proxy Filing - Key votes include director elections, auditor ratification, and stock plan amendment.CNXC
Proxy Filing - 2026 meeting covers board elections, auditor, pay, and equity plan amid strong governance and ESG.CNXC
Proxy Filing - Record revenue and cash flow in 2025, with 2026 growth expected despite a goodwill impairment.CNXC
Q4 2025 - Q2 revenue up 47.4% to $2.38B; guidance raised despite net income decline on higher costs.CNXC
Q2 2024 - FY25 guidance projects modest revenue growth, margin expansion, and higher free cash flow.CNXC
Q4 2024